Anchor Biologics Wins the 2019 Cade Prize
The Cade Museum for Creativity and Invention announced Anchor Biologics as the first place winner of its 2019 Cade Prize. Anchor Biologics... Read More
UF Health Researcher’s Gene Therapy Technique Being Further Developed to Treat Neurodegenerative Disorders
A gene therapy technique discovered by a University of Florida Health researcher and her colleague is now being used to develop treatments... Read More
Gainesville-Based, Anchor Biologics Wins 2019 Cade Prize
The Cade Museum for Creativity & Invention has announced that Anchor Biologics has won the 2019 Cade Prize, receiving a $25,000 cash... Read More
UF Incubator Firm Gets $2 Million Boost for New Screen Technology
Two resident companies at a University of Florida business incubator recently received a hefty investment from Samsung to further develop technology that... Read More
AI Could Help Citrus Growers Find, Detect Dangerous Psyllids
Precision agriculture engineer Yiannis Ampatzidis sees a day when citrus farmers use artificial intelligence to detect the pin-sized insects that can infect... Read More
UF Startup Combatting Mosquito Diseases Featured at National Showcase
UF has been nationally recognized for working with a pest control company to prevent the spread of insect-borne diseases. On April 10,... Read More
How Nature’s Creatures Are Helping Us To Live Better Lives
UF researchers are developing synthetic versions of shark skin to be used in hospitals and reduce bacterial infections, one of the biggest... Read More
UF Startup Florida Insect Control Group Featured at University Innovation & Entrepreneurship Showcase in Washington, D.C.
University of Florida researchers behind Florida Insect Control Group, a pest control device company, originally intended to protect deployed military personnel from... Read More
AGTC Announces Reaching Enrollment Milestones in Phase 1/2 Clinical Trials
UF startup Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment... Read More
Roche Makes $4.8 Billion Bid for Spark Therapeutics and Its Gene Therapy Programs
Research by UF’s Dr. William Hauswirth is behind the gene therapy that resulted in Spark Therapeutics’ Luxturna, an FDA-approved gene therapy for... Read More
